ED
HCA icon

Exane Derivatives’s HCA Healthcare HCA Stock Holding History

Exane Derivatives’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$26.4K Hold
157
– – 0.02% 352
2022
Q1 		$39.3K Sell
157
-321
-67% -$80.6K 0.01% 595
2021
Q4 		$123K Sell
478
-520
-52% -$127K 0.03% 418
2021
Q3 		$242K Sell
998
-23
-2% -$5.62K 0.06% 345
2021
Q2 		$224K Sell
1,021
-207
-17% -$42.2K 0.05% 367
2021
Q1 		$231K Buy
1,228
+40
+3% +$7.05K 0.07% 280
2020
Q4 		$195K Buy
1,188
+159
+15% +$23.2K 0.06% 314
2020
Q3 		$128K Buy
1,029
+38
+4% +$4.7K 0.04% 262
2020
Q2 		$96.2K Sell
991
-3,494
-78% -$363K 0.03% 300
2020
Q1 		$403K Buy
4,485
+4,467
+24,817% +$578K 0.11% 140
2019
Q4 		$2.65K Buy
18
+7
+64% +$940 ﹤0.01% 477
2019
Q3 		$1.32K Hold
11
– – ﹤0.01% 524
2019
Q2 		$1.49K Sell
11
-1
-8% -$126 ﹤0.01% 531
2019
Q1 		$1.56K Sell
12
-110
-90% -$14.8K ﹤0.01% 467
2018
Q4 		$15.2K Sell
122
-31,986
-100% -$4.29M ﹤0.01% 442
2018
Q3 		$4.47M Buy
32,108
+20,404
+174% +$2.54M 0.84% 23
2018
Q2 		$1.2M Sell
11,704
-356
-3% -$36K 0.2% 110
2018
Q1 		$1.17M Buy
+12,060
New +$1.17M 0.23% 113
2017
Q3 		– Sell
-26,094
Closed -$2.27M – 607
2017
Q2 		$2.27M Sell
26,094
-5,228
-17% -$442K 0.49% 48
2017
Q1 		$2.79M Buy
+31,322
New +$2.61M 0.63% 48
2016
Q3 		– Sell
-154,498
Closed -$11.9M – 638
2016
Q2 		$11.9M Buy
+154,498
New +$12.2M 1.96% 19
2015
Q3 		– Sell
-284,819
Closed -$25.8M – 553
2015
Q2 		$25.8M Buy
+284,819
New +$22.8M 2.78% 1

Other funds holding HCA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Exane Derivatives's HCA Position: Q2 2022 in Review

Exane Derivatives held its HCA Healthcare (HCA) position steady in Q2 2022 at 157 shares worth $26.4K. The position accounts for 0.02% of the portfolio, ranked #352.

Exane Derivatives first reported a position in HCA in Q2 2015 and has held it in 22 quarters since. The position peaked at $25.8M in Q2 2015. 884 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

  • Exane Derivatives held 157 shares of HCA Healthcare worth $26.4K as of Q2 2022.
  • Exane Derivatives left its HCA Healthcare share count unchanged in Q2 2022.
  • HCA Healthcare made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #352 holding.
  • Exane Derivatives first reported a position in HCA Healthcare in Q2 2015 and has held it in 22 quarters since.
  • Exane Derivatives's HCA Healthcare position peaked at $25.8M in Q2 2015.
  • 884 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.